人类KV7.4通道的两步电压传感器激活,以及与聋相关的突变的影响
Mario Nappi1, Damon J A Frampton2, Ali S Kusay2
1Department of Neuroscience, University of Naples "Federico II", Naples, Italy.
Nature communications
|February 4, 2026
概括
对于听力至关重要的KCNQ4通道,通过多个步骤激活. 导致听力损失的突变会通过破坏关键通道组件的稳定性来损害这种激活.
科学领域:
- 分子生物学分子生物学
- 神经科学是一个神经科学.
- 生物物理学的生物物理.
背景情况:
- KCNQ4通道 (KV7.4) 对于内耳毛细胞功能至关重要.
- 在KCNQ4中功能丧失的变体会导致渐进性听力损失 (DFNA2).
研究的目的:
- 为了研究电压传感器域 (VSD) 激活和KV7.4通道打开之间的合机制.
- 了解DFNA2相关突变如何影响VSD动态和通道功能.
主要方法:
- 使用双重光体和脉冲激发的电压流量测量以光学追踪KV7.4 VSD激活.
- 模拟分子动力学以分析R216H突变的影响.
主要成果:
- KV7.4 VSD激活涉及多个电压依赖的过渡.
- 一些VSD转换表现出类似于通道门的动力学和电压依赖性.
- 与DFNA2相关的R216H突变通过破坏活跃的VSD状态来阻碍VSD运动和通道开通.
结论:
- KV7.4 VSD激活至少有两个步骤:一个快速的初始运动和更慢的后续转换.
- 这些发现阐明了KV7.4通道的封闭机制以及DFNA2听力损失的分子基础.
更多相关视频
11:39Assessment of Audio-Tactile Sensory Substitution Training in Participants with Profound Deafness Using the Event-Related Potential Technique
Published on: September 7, 2022
2.7K
04:32Sound Source Localization Testing in Single-sided Deafness Following Bone Conduction Intervention
Published on: December 20, 2024
889
相关概念视频
Voltage-gated Ion Channels
10.9K
Voltage-gated ion channels are transmembrane proteins that open and close in response to changes in the membrane potential. They are present on the membranes of all electrically excitable cells such as neurons, heart, and muscle cells.
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several types of...
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several types of...
10.9K
Ion Channels
91.5K
The movement of ions like sodium, potassium, and calcium into and out of the cell is essential to maintain the electrochemical gradient in living cells. The ion channels—a class of membrane transport proteins—help maintain this ionic gradient for the smooth functioning of physiological activities such as maintaining cell size and volume, conducting nerve impulses, and gas and nutrient exchange.
Ion channels are specialized integral membrane proteins on the plasma membrane that allow...
Ion channels are specialized integral membrane proteins on the plasma membrane that allow...
91.5K
Mutations
94.5K
Overview
94.5K
Mutations
44.6K
Mutations are changes in the sequence of DNA. These changes can occur spontaneously or they can be induced by exposure to environmental factors. Mutations can be characterized in a number of different ways: whether and how they alter the amino acid sequence of the protein, whether they occur over a small or large area of DNA, and whether they occur in somatic cells or germline cells.
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
44.6K
Viral Mutations
39.9K
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
39.9K
Antiepileptic Drugs: Potassium Channel Activators
694
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
694
